Search research articles
Contact Us
Filters
Showing results (361-370 of 384) with videos related to
Page
of 39
Sort By:
Bone Marrow Transplantation
|
October 5, 2021
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis
Oren Pasvolsky, Moshe Yeshurun, Raphael Fraser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2023
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium
Yucai Wang, Preetesh Jain, Frederick L Locke, et al.
Transplantation and Cellular Therapy
|
June 16, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival
Gurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, et al.
Blood Advances
|
February 24, 2026
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World Analysis
Carlyn Rose Tan, Saad Z Usmani, Andriy Derkach, et al.
American Journal of Hematology
|
March 21, 2026
The Safety and Efficacy of Commercial BCMA-Directed CAR T-Cell Therapy in Systemic AL Amyloidosis With Concurrent Myeloma
Matthew J Rees, Raffaella Cassano Cassano, Melinda Tan, et al.
Transplantation and Cellular Therapy
|
June 27, 2026
Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR Analysis
Kitsada Wudhikarn, Lohith Gowda, Qiran Ye, et al.
American Journal of Hematology
|
October 11, 2025
Predictors of Delayed Responses to Teclistamab in Multiple Myeloma After Initial Non-Response
Rahul Banerjee, Gurbakhash Kaur, Beatrice M Razzo, et al.
Leukemia
|
January 27, 2025
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma
Luciano J Costa, Rahul Banerjee, Hira Mian, et al.
Blood Advances
|
December 3, 2024
Development and validation of predictive models of early immune effector cell-associated hematotoxicity
Emily C Liang, Jennifer J Huang, Andrew J Portuguese, et al.
Journal of the American Chemical Society
|
July 21, 2020
High-Resolution XFEL Structure of the Soluble Methane Monooxygenase Hydroxylase Complex with its Regulatory Component at Ambient Temperature in Two Oxidation States
Vivek Srinivas, Rahul Banerjee, Hugo Lebrette, et al.
Page
of 39
Search research articles
Search
Showing results (361-370 of 384) with videos related to
Sort By:
Page
of 39
Bone Marrow Transplantation
|
October 5, 2021
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis
Oren Pasvolsky, Moshe Yeshurun, Raphael Fraser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 8, 2023
Brexucabtagene Autoleucel for Relapsed or Refractory Mantle Cell Lymphoma in Standard-of-Care Practice: Results From the US Lymphoma CAR T Consortium
Yucai Wang, Preetesh Jain, Frederick L Locke, et al.
Transplantation and Cellular Therapy
|
June 16, 2026
Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival
Gurbakhash Kaur, Jennifer Logue, Ruta Brazauskas, et al.
Blood Advances
|
February 24, 2026
Early Mortality with Bispecific Antibody Therapy in RRMM: An IMWG Immunotherapy Database Real-World Analysis
Carlyn Rose Tan, Saad Z Usmani, Andriy Derkach, et al.
American Journal of Hematology
|
March 21, 2026
The Safety and Efficacy of Commercial BCMA-Directed CAR T-Cell Therapy in Systemic AL Amyloidosis With Concurrent Myeloma
Matthew J Rees, Raffaella Cassano Cassano, Melinda Tan, et al.
Transplantation and Cellular Therapy
|
June 27, 2026
Infections within 100 days of idecabtagene vicleucel and impact on survival for relapsed/refractory multiple myeloma: A CIBMTR Analysis
Kitsada Wudhikarn, Lohith Gowda, Qiran Ye, et al.
American Journal of Hematology
|
October 11, 2025
Predictors of Delayed Responses to Teclistamab in Multiple Myeloma After Initial Non-Response
Rahul Banerjee, Gurbakhash Kaur, Beatrice M Razzo, et al.
Leukemia
|
January 27, 2025
International myeloma working group immunotherapy committee recommendation on sequencing immunotherapy for treatment of multiple myeloma
Luciano J Costa, Rahul Banerjee, Hira Mian, et al.
Blood Advances
|
December 3, 2024
Development and validation of predictive models of early immune effector cell-associated hematotoxicity
Emily C Liang, Jennifer J Huang, Andrew J Portuguese, et al.
Journal of the American Chemical Society
|
July 21, 2020
High-Resolution XFEL Structure of the Soluble Methane Monooxygenase Hydroxylase Complex with its Regulatory Component at Ambient Temperature in Two Oxidation States
Vivek Srinivas, Rahul Banerjee, Hugo Lebrette, et al.
Page
of 39